Vanguardia, Khinn Luiz Roi C.
HRN: 23-83-02 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/02/2025
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
03/02/2025
03/09/2025
TOPICAL
25g
BID
Superficial Partial Thickness Burn 9% TBSA
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes